CHALFONT ST. GILES, England--(BUSINESS WIRE)--June 7, 2006--GE Healthcare (NYSE:GE):
New York Blood Center's National Cord Blood Program
is the first to automate the processing, cryopreservation and
storage of cord blood stem cell units to achieve the
highest standards of quality and consistency
CHALFONT ST GILES, England--(BUSINESS WIRE)--June 5, 2006--GE Healthcare, a division of the General Electric Company (NYSE:GE), announced today that it has initiated a first-in-man clinical study designed to validate information provided by a molecular imaging agent in evaluating the extent and nature of cancer. Specifically, this proprietary positron emission tomography (PET) agent has a biological mechanism to track the process of angiogenesis, the formation of new blood vessels in the body.
CHALFONT ST GILES, United Kingdom--(BUSINESS WIRE)--May 24, 2006--GE Healthcare and DiscoveRx (Fremont, CA) have entered into an exclusive distribution agreement for all HitHunter(TM) cAMP Enzyme Fragment Complementation (EFC)-based assays, designed for high throughput, non-radioactive screening of compounds in drug discovery.
WAUKESHA, Wis.--(BUSINESS WIRE)--May 23, 2006--GE Healthcare announced today the introduction of a new high-performance compact ultrasound system to address the growing demand for clinically specialized, real-time imaging at the point of care. The LOGIQ e, the newest member of GE's Compact Series of ultrasound systems, is designed with the speed, image quality and applications to support real-time clinical decisions in emergency settings.
WAUKESHA, Wis. & ST. PAUL, Minn.--(BUSINESS WIRE)--May 16, 2006--GE Healthcare (NYSE:GE) and St. Jude Medical, Inc. (NYSE:STJ) today announced a significant development and collaboration agreement that is intended to bring an integrated imaging and monitoring capability to cardiac catheterization labs around the world. Under terms of the agreement, GE and St.
business unit
tags
WAUKESHA, Wis.--(BUSINESS WIRE)--May 15, 2006--GE, the world's leading ultrasound company, is introducing four new clinically specialized ultrasound systems to address healthcare providers' growing demand for sophisticated, real-time imaging at the point of care. GE's Compact Series is a new and revolutionary line of ultrasound products that places the power and imaging capabilities of a high-performance, 400-pound system into a laptop-size design.
WASHINGTON--(BUSINESS WIRE)--May 10, 2006--GE Healthcare, a unit of General Electric Company (NYSE:GE), today announced that it has received U.S. Food and Drug Administration (FDA) clearance for the Voluson i, the world's first and only 4D compact ultrasound system designed specifically for women's healthcare, including obstetric, gynecological, and other clinical applications. This new compact system allows clinicians to make real-time diagnoses, particularly for high-risk patients, by providing high-quality 4D imaging to wherever the patient is located.
business unit
tags
